TSMC Gets Institutional and Insider Conviction Amid Supply Risks as Unilever Fades with CEO Selling and Diverging Price Action

The noise from Wall Street analysts and corporate press releases is loud, but the only signal that truly matters is what insiders and institutions do with their own money. When the smart money buys, it's a vote of confidence. When it sells, it's a warning. The data for TSMC and Unilever tells a starkly different story.

For TSMC, the smart money is piling in. Perigon Wealth Management LLC, a notable institutional player, boosted its stake by 29.6% in the fourth quarter, adding over 2,500 shares. This isn't an isolated move; several other firms also increased their holdings. More telling is the action from within the company. A senior vice president, Lin Shyue-Shyh, made a direct, open-market purchase of 3,000 shares at $54.72 each. This is skin in the game. It shows alignment of interest at a time when Citigroup recently raised its price target, citing AI demand. The institutional accumulation and insider buying here signal conviction that the company's long-term trajectory is intact.

The picture for Unilever is the opposite. Over the last 90 days, insiders have been net sellers, with a total transaction value of approximately -$3.57 million. Executives like Heiko Schipper and Richard Slater have executed significant sales, contributing to a net outflow of around -$2.44 million. While there were some smaller buys earlier in the period, the dominant trend is clear. This whale wallet activity-selling while the stock has climbed 6.2% over the same period-suggests a lack of skin in the game from those with the deepest knowledge of the business. It's a classic divergence: the stock price is moving higher, but the people who know it best are taking money off the table.

The bottom line is simple. In TSMC, you see institutional accumulation and insider buying-a powerful alignment of interest. In Unilever, you see institutional and insider selling-a clear signal of caution. When the smart money moves, it's worth watching.

TSMC: Navigating Supply Constraints and the Quiet Period

The bullish institutional bets on TSMC are backed by undeniable demand. The company's revenue surged 37% year-over-year in January and 22% in February, showing the AI megatrend is still a powerful engine. But the smart money isn't just buying the headline growth; it's betting on TSMC's ability to manage the real-world bottlenecks that could choke that growth.

The risks are tangible. Supply constraints are emerging as a key bottleneck, with capacity limitations restricting how quickly AI demand can be fulfilled. This isn't theoretical. The company faces a dual threat from geopolitical instability and physical shortages. The ongoing Iran conflict disrupts energy flows critical to Taiwan, where TSMC imports almost 95% of its energy. Simultaneously, a shortage of helium-a vital gas for chip manufacturing-is aggravating the supply problem. These are not minor hiccups; they are systemic vulnerabilities that could limit production even as orders pour in.

TSMC's strategic response is a long-term bet on resilience. The company is expanding capacity in Japan, with 3-nanometre production planned for 2028 at its second factory. This move diversifies its footprint and secures a foothold in a key market, but it's a multi-year play. For now, the immediate test is execution amid these constraints.

That brings us to the critical near-term catalyst: the upcoming quiet period from April 6 to 15. During these nine days, TSMC will issue no new guidance or commentary. The entire market will be waiting for the March sales report on April 10 to see if the company can still deliver strong numbers despite the supply risks. A beat would confirm the AI demand story is intact and that TSMC is effectively managing its bottlenecks. A miss, however, would validate the concerns about capacity and geopolitics, potentially undermining the institutional confidence that has been building.

The setup is clear. The smart money is positioned for growth, but the coming sales data will be the real test of whether that growth is sustainable or if supply constraints are the new ceiling.

Unilever: A Shrinking Portfolio and CEO Selling

The strategic pivot at Unilever is clear. The company is reshaping its portfolio toward higher-growth categories like Beauty & Wellbeing, a multi-year shift that aims to build a "brand portfolio for the future." This discipline is evident in actions like the completed Ice Cream demerger and targeted acquisitions. Yet the smart money is not buying the promise of that future. It is selling the present.

The underlying business performance is under pressure. In the fourth quarter, Unilever's underlying sales growth slowed to just 1.3%, with Europe and Foods specifically cited as weak. This is the reality the company is trying to fix. The strategic shift is a necessary long-term bet, but it is not a near-term catalyst for the stock. For now, the numbers show a business struggling to grow.

The most telling signal comes from the CEO. In February 2026, Fernando Fernandez executed a major sale of 909,668 GBP shares. This was a significant transaction, dwarfing the smaller buys from other executives earlier in the period. It stands in stark contrast to his own statement of confidence in 2026. When the CEO sells while hyping the year ahead, it raises a red flag. It suggests a lack of skin in the game, a personal bet against the stock's near-term trajectory even as the company's own guidance points to improvement.

This insider selling is part of a broader trend. Over the last 90 days, insiders have been net sellers, with a total transaction value of approximately -$3.57 million. The stock has climbed 6.2% over that same period, creating a classic divergence. The whale wallets are taking money off the table as the price moves higher, while the people with the deepest knowledge of the business are exiting.

The bottom line is that Unilever's strategic shift is a long-term play, not a quick fix. The smart money is not betting on it yet. With underlying growth slowing and the CEO selling a massive block of stock, the current setup suggests a fading opportunity, not a turnaround.

Catalysts and What to Watch

The smart money has placed its bets. Now, the market must provide the proof. The coming weeks will test whether the institutional accumulation in TSMC and the insider selling in Unilever were prescient moves or costly misjudgments.

For TSMC, the critical test arrives on April 10. The company will report its March sales, a real-time snapshot of AI demand amid the mounting supply constraints and geopolitical risks. The data point will confirm or contradict the bullish thesis. A strong report would validate the institutional confidence, showing TSMC is effectively managing bottlenecks to fulfill orders. A miss, however, would signal that capacity and instability are the new ceiling, potentially undermining the entire growth narrative that has driven the stock higher. The quiet period from April 6 to 15 makes this report even more pivotal; it's the only guidance the market will get until then.

For Unilever, the focus shifts to its Q1 earnings. The strategic pivot toward Beauty & Wellbeing and premium segments needs to show tangible results. Investors must see signs of volume growth and margin improvement in these new focus areas to justify the long-term bet. The current setup-a slowing underlying sales growth of just 1.3% last quarter and a CEO selling a massive block of stock-demands clear evidence of a turnaround. Any earnings miss or weak outlook would reinforce the caution signaled by insider selling.

Beyond these specific events, the filings themselves are the ultimate barometer. For TSMC, watch for any new institutional accumulation or insider buying that could signal continued confidence. For Unilever, monitor future insider filings for a reversal in the selling trend. A sustained period of net buying from executives would be a powerful signal that the whale wallets are finally seeing value where the smart money has already positioned. Until then, the divergence between price action and insider behavior remains the most telling story.